FDA Clears Gilead's Second TAF-Based HIV Regimen (Odefsey)FDA Clears Gilead's Second TAF-Based HIV Regimen (Odefsey)

Odefsey combines emtricitabine, rilpivirine, and tenofovir alafenamide and 'represents the smallest pill of any single tablet regimen for the treatment of HIV,' the company says. FDA Approvals
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Alert Source Type: news